AgomAb Therapeutics NV · NASDAQ:AGMB
Epstein David R bought 10,000 AgomAb Therapeutics NV shares (Form 4)
Traded Oct 21, 2026 · Filed Oct 22, 2026
On Oct 21, 2026, Epstein David R (Director) bought 10,000 AgomAb Therapeutics NV shares at an average US$8.88 for US$88,800, leaving 25,000 shares. Filed Oct 22, 2026 (Form 4).
- Bought
- 10,000 shares
- Price
- US$8.88 average (US$8.86 to US$8.90)
- Value
- US$88,800
- Holding after
- 25,000 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Common shares | Buy | 5,000 | US$8.86 | 20,000 | Direct |
| Oct 21, 2026 | Common shares | Buy | 5,000 | US$8.90 | 25,000 | Direct |
Source
Download original · View original at SEC